Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) were produced as a carrier for heparin-binding growth factors (GFs) and for various adhesive cells. A mixture of low-molecular-weight heparin (MW: approximately 5000 Da, 6.4 mg/mL) and protamine (MW: approximately 3000 Da, 10 mg/mL)...
Saved in:
Main Authors: | Shingo Nakamura (Author), Masanori Fujita (Author), Yasutaka Mori (Author), Hidemi Hattori (Author), Megumi Takikawa (Author), Masayuki Ishihara (Author), Satoko Kishimoto (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate
by: John Hogwood, et al.
Published: (2017) -
Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth
by: Takabayashi Y, et al.
Published: (2016) -
Improved method for synthesis of low molecular weight protamine-siRNA conjugate
by: Zhili Yu, et al.
Published: (2018) -
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023) -
Protamine-Based Strategies for RNA Transfection
by: Natalia Teresa Jarzebska, et al.
Published: (2021)